Thermo Fisher Scientific is the world leader in serving science, with a mission to enable customers to make the world healthier, cleaner, and safer. The company supports scientific research, healthcare, and innovation by providing a comprehensive portfolio of instruments, reagents, consumables, software, and services that help customers solve complex challenges and advance discovery.Serving customers across academic, government, biotechnology, pharmaceutical, clinical, and industrial markets, Thermo Fisher combines global scale with deep scientific and technical expertise to support work spanning research and development, diagnostics, and manufacturing. The company’s integrated solutions are designed to improve productivity, accelerate timelines, and enhance data quality across a wide range of scientific applications.Serving customers across academic, government, biotechnology, pharmaceutical, clinical, and industrial markets, Thermo Fisher combines global scale with deep scientific and technical expertise to support work spanning research and development, diagnostics, and manufacturing. The company’s integrated solutions are designed to improve productivity, accelerate timelines, and enhance data quality across a wide range of scientific applications.With operations around the world, Thermo Fisher Scientific is committed to delivering reliable, high-quality products and services while fostering collaboration and innovation. Guided by a strong culture of integrity, inclusion, and sustainability, the company continues to invest in technologies and partnerships that help advance science and address some of the world’s most pressing health and environmental challenges.
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.
Explore how blood-based biomarkers perform across Alzheimer’s disease stages, including AIBL Study findings comparing p-Tau217 and other markers against amyloid-beta and tau PET reference standards.
Explore how super-resolution microscopy enables particle-level characterization of lipid nanoparticle composition, cargo loading, heterogeneity, and stability, providing complementary insights for formulation development and optimization.
The placements follow the commercial launch of Pyxa at the Advances in Genome Biology and Technology (AGBT) meeting in February 2026 and mark the company's transition from Early Access into global commercial availability.
The CellRaft AIR streamlines antibody discovery with imaging, functional screening, and gentle isolation of viable single B cells and hybridomas, helping verify monoclonality and identify high producing clones faster.
Load plasma directly into prefilled cartridges, no pretreatment, no ethanol. Under 30 minutes of instrument run time, up to 48 samples in parallel, with a high-throughput format also available.
Two Paige tools, powered by the Virchow pathology foundation model, are now available within a single image management workspace for oncology research.
